Venarus tab. p / o captivity. 500 mg # 60

Release form, composition and packaging

Orange-pink film-coated tablets, biconvex, oblong with rounded ends, with a risk

in cross section, the core is from grayish-yellow to brownish-gray.

1 tab.

hesperidin 50 mg

diosmin 450 mg

microcrystalline cellulose - 62 mg, sodium carboxymethyl starch (sodium starch glycolate) - 27 mg, gelatin - 31 mg, talc - 6 mg, magnesium stearate - 4 mg.

Shell composition: hypromellose (hydroxypropyl methylcellulose) - 20.7 mg, macrogol 6000 (polyethylene glycol 6000) - 3.38 mg, sodium lauryl sulfate - 0.1 mg, magnesium stearate - 1.24 mg, titanium dioxide - 3.94 mg, iron oxide red - 0.3 mg, iron oxide yellow - 0.34 mg.

10 pieces.

- contour cell packages (2) - cardboard packs.

10 pieces.

- contour cell packages (3) - cardboard packs.

10 pieces.

- contour cell packages (4) - cardboard packs.

10 pieces.

- contour cell packaging (6) - cardboard packs.

10 pieces.

- contour cell packages (7) - cardboard packs.

10 pieces.

- contoured cell packaging (8) - cardboard packs.

10 pieces.

- contour cell packaging (9) - cardboard packs.

15 pcs.

- contour cell packages (2) - cardboard packs.

15 pcs.

- contour cell packages (3) - cardboard packs.

15 pcs.

- contour cell packages (4) - cardboard packs.

15 pcs.

- contour cell packaging (6) - cardboard packs.

15 pcs.

- contour cell packages (7) - cardboard packs.

15 pcs.

- contoured cell packaging (8) - cardboard packs.

15 pcs.

- contour cell packaging (9) - cardboard packs.

pharmachologic effect

Venotonic and venoprotective drug.

It has an angioprotective and venotonic effect.

Reduces the elasticity of veins, increases their tone and reduces venous congestion

reduces the permeability, fragility of capillaries and increases their resistance

improves microcirculation and lymph drainage.

With systematic use, it reduces the severity of clinical manifestations of chronic venous insufficiency of the lower extremities of an organic and functional nature.

Pharmacokinetics

The main excretion of the drug occurs in the feces.

With urine, on average, about 14% of the taken amount of the drug is excreted.

T1 / 2 is 11 hours. The drug undergoes active metabolism, which is confirmed by the presence of phenolic acids in the urine.

Indications for use

Therapy for symptoms of venous lymphatic insufficiency:

- pain

- cramps of the lower extremities

- a feeling of heaviness and fullness in the legs

- tiredness" of the legs.

Therapy of manifestations of venous-lymphatic insufficiency:

- edema of the lower extremities

- trophic changes in the skin and subcutaneous tissue

- venous trophic ulcers.

Symptomatic therapy of acute and chronic hemorrhoids.

Contraindications for use

- hypersensitivity to active ingredients or excipients that make up the drug

- taking the drug is not recommended for lactating women.

Dosage regimen

Inside.

The recommended dose for venous lymphatic insufficiency is 2 tablets / day (for 1 or 2 doses): in the morning, afternoon and / or evening, during meals.

The course of treatment can be several months (up to 12 months).

In case of recurrence of symptoms, on the recommendation of a doctor, the course of treatment can be repeated.

The recommended dose for acute hemorrhoids is 6 tablets / day: 3 tablets each.

in the morning and 3 tab.

in the evening for 4 days, then 4 tab. / day: 2 tab.

in the morning and 2 tab.

in the evening for the next 3 days.

The recommended dose for chronic hemorrhoids is 2 tablets / day during meals.

Overdose

Overdose cases have not been described.

In case of an overdose of the drug, the patient should immediately seek medical attention.

Side effect

The incidence of adverse reactions is presented as follows: very often (& g

Name ENG

VENARUS

Clinical and pharmacological group

Venotonic drug.

ATX code

Diosmin in combination with other drugs

Dosage

50mg + 450mg

Structure

1 tablet contains: Active substances: diosmin - 0.45 g, hesperidin - 0.05 g. Excipients (core): gelatin, magnesium stearate, microcrystalline cellulose, starch, sodium glycolate, talc.

Excipients (shell): polyethylene glycol 6000, magnesium stearate, hydroxypropyl methylcellulose, sodium lauryl sulfate, titanium dioxide, iron oxide red, iron oxide yellow.

Indications

Venarus is indicated for the treatment of symptoms of chronic venous disease (elimination and relief of symptoms).

Therapy for symptoms of venous lymphatic insufficiency:

- cramps of the lower extremities

- a feeling of heaviness and fullness in the legs

- pain

- "tiredness" of the legs.

Therapy of manifestations of venous-lymphatic insufficiency:

- edema of the lower extremities

- trophic changes in the skin and subcutaneous tissue

- venous trophic ulcers.

Symptomatic therapy of acute and chronic hemorrhoids.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

INN / Active ingredient

hesperidin, diosmin

Contraindications

hypersensitivity to active ingredients or excipients that make up the drug

taking the drug is not recommended for lactating women.

Specifications

Category

Diseases of the veins

Scope of the drug

Heart, vessels, blood

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

60

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Obolenskoe FP

,

FP Obolenskoe

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Venotonic and venoprotective agent

Anatomical and therapeutic characteristics

C05CA53 Diosmin, in combination with other drugs

Dosage form

Film-coated tablets

Dosage (volume) of the substance in the preparation

0.45 mg, 0.05 mg

Expiration date in days

1460

Package weight, g

thirty

Mode of application

:

Inside. < br> < br> Recommended dose for venous-lymphatic insufficiency: 2 tablets per day: 1 tablet - in the middle of the day and 1 tablet - in the evening, during meals. < br> < br> Recommended dose for acute hemorrhoids: 6 tablets per day: 3 tablets in the morning and 3 tablets in the evening for 4 days, then 4 tablets per day: 2 tablets in the morning and 2 tablets in the evening for the next 3 days.

Information on technical characteristics, delivery set, country of manufacture "